ENTITY
D.Western Therapeutics Institute Inc.

D.Western Therapeutics Institute Inc. (4576 JP)

25
Analysis
Health Care • Japan
D.Western Therapeutics Institute Inc.(DWTI) is a biotechnology (bio-venture) company that focuses on development of new drugs. The Company's focus is on protein kinase inhibitors. DWTI discovers and develops several drugs, such as antiglaucoma, antihypertensive, neuroprotective, antithrombogenic, antiatherosclerosis and anticancer.
more
•21 Jul 2025 19:37•Issuer-paid

News Flash: D. Western Therapeutics Institute (4576 JP) - July 17, 2025

DWTI announced plans to advance development of in-house discovered pipeline candidate H-1129 —Also announced issuance of Series 13 Share...

Share
•03 Jun 2025 20:43•Issuer-paid

D. Western Therapeutics Institute (DWTI) (4576 JP) - Q1 Follow-Up - June 3, 2025

SIR believes DWTI has entered an exciting new phase given significant advances in pipeline development achieved over the last year.

Share
•22 Apr 2025 01:37•Issuer-paid

D. Western Therapeutics Institute (DWTI) 4576 JP - Full Report

SIR believes DWTI has entered an exciting new phase given significant advances in pipeline development achieved over the last 12 months.

Share
•04 Apr 2025 05:45•Issuer-paid

D. Western Therapeutics Institute (DWTI) (4576 JP) - Q4 Follow-Up

SIR believes DWTI has entered an exciting new phase given significant advances in pipeline development achieved over the last 12 months.

Share
•21 Feb 2025 06:29•Issuer-paid

4576 JP - Notice of Approval of Ophthalmic Surgical Aid “DW-1002” in China

The graph below shows the annual trend of DW-1002 royalty income to DWTI from DORC. In China, it is scheduled to be launched under the product name...

Share
x